p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

Por Fondevila, C, Metges, J P, Fuster, J, Grau, J J, Palacín, A, Castells, A, Volant, A, Pera, M
Publicado em 2004

Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?

Por Metges, J-P, Gibault, L, Conan-Charlet, V, Lozac'H, P, Robaszkiewicz, M, Bessaguet, C, Lagarde, N, Volant, A
Publicado em 2006

Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer

Por Gibault, L, Metges, J-P, Conan-Charlet, V, Lozac'h, P, Robaszkiewicz, M, Bessaguet, C, Lagarde, N, Volant, A
Publicado em 2005

p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions.

Por Volant, A, Nousbaum, J B, Giroux, M A, Roué-Quintin, I, Metges, J P, Férec, C, Gouérou, H, Robaszkiewicz, M
Publicado em 1995

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

Por Conroy, T, Viret, F, François, E, Seitz, J F, Boige, V, Ducreux, M, Ychou, M, Metges, J P, Giovannini, M, Yataghene, Y, Peiffert, D
Publicado em 2008

PD-032 Is there an impact of the number of metastases in the outcome of potentially resectable metastatic colorectal cancer patients receiving bevacizumab-based regimen in 1st line...

Por Metges, J.-P., Bennouna, J., Rivoire, M., Elias, D., Bonnetain, F., Dourthe, L., Ben Abdelghani, M., Radji, R., Laplaige, P., Petit Laurent, F., Sébastien, K., Telliez, J., Malka, D.
Publicado no Ann Oncol (2016)

P-136 Evolution of efficacy and safety of cetuximab with the determination of RAS status in Metastatic Colorectal Cancer (mCRC) elderly patients

Por Metges, J.-P., Capitain, O., Ramée Jean, F., Raoul Jean, L., Douillard, J.-Y., Etienne Pierre, L., Cumin, I., Dupuis, O., Faroux, R., Coulon, M.-A., Deguiral, P., Le Rol, A., Achour Nacr, E., Gorlaouen, A., Bouret, J.-F., Marhuenda, F., Déniel Lagadec, D., Grudé, F.
Publicado no Ann Oncol (2016)

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus o...

Por Metges, J. P., Lebot, M. A., Faroux, R., Riaud, F., Gamelin, E., Capitain, O., Guérin Meyer, V., Leynia, P., Douillard, J. Y., Senellart, H., Rochard, S., Louvigné, C., Campion, L., Dupuis, O., Grollier, C., Achour, N. A., Person, B., Raoul, J. L., Boucher, E., Bertrand, C., Ramée, J. F., Guivarch, L., Etienne, P. L., Roussel, S., Desclos, H., Julien, M. N., Labarre, M. I., Klein, V., Bessard, R., Stampfli, C., Royet, F., Faycal, J., Gouva, S., Le Bihan, G., Couturier, M., Gourlaouen, A., Bertholom, C., Porneuf, M., Jobard, E., Peguet, E., Grasset, D., Bouret, J. F., Bicheler, V., Ulvoas, A., Miglianico, L., Chouzenoux, C., Deguiral, P., Derenne, L., Martin, D., Langlet, P. Michel, Bodin, C., Rossi, V., Barré, S., Cojocarasu, O., Naveau Ploux, C., Vidal, A. M., Cumin, I., Egreteau, J., Brouard, A., Matysiak Budnik, T., Thomaré, P., Le Bris Michel, A. S., Piriou, G., Largeau, R., Elhannani, C., Crespeau, E., Suberville, F., Bourgeois, H., Riche, C., Lagadec, D. Déniel, Marhuenda, F., Grudé, F.
Publicado no Oncologie (Paris) (2014)